Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Description of the Impact of Symptoms on Quality of Life in HHT Disease: DISQUO

NCT07191639 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT07191639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07191639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Description of the Impact of Symptoms on Quality of Life in HHT Disease: DISQUO
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
December 1, 2024
Completion date
May 1, 2025
Enrollment
185 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary hemorrhagic telangiectasia (hht)